THE ADVERSE EFFECTS OF IN CENTRAL SEROUS CHORIORETINOPATHY

DE NIJS E.*, BRABANT P.*, DE LAEY J.J.*

SUMMARY (CRSC). Drie patiënten worden voorgesteld waarbij CRSC geïnduceerd of verergerd werd na corticothe- The purpose of this paper is to report on the possi- rapie. Ondanks veelvuldige publicaties die deze bij- ble deleterious effect of corticosteroids in central se- werking van corticoïden aantoonden bij patiënten rous chorioretinopathy (CSCR). We will describe three met CRSC, gebruiken sommige oogartsen nog steeds patients in whom CSCR was induced or aggravated steroïden bij CRSC. Steroïden zijn vaak nodig bij de by corticosteroids. Despite multiple reports describ- behandeling van uiteenlopende aandoeningen. Oog- ing the onset of CSCR or aggravation of existing le- artsen moeten op de hoogte zijn van deze schade- sions with corticosteroids, they are still used by some lijke effecten van corticoïden in al hun toedienings- ophthalmologists for the treatment of CSCR. Corti- vormen. costeroids are also widely used for the treatment of a variety of diseases. Ophthalmologists should be KEY-WORDS aware that corticosteroids independently of the way of administration may cause this type of complica- Central serous chorioretinopathy - side effect tion. - RÉSUMÉ MOTS-CLÉS Le but de notre rapport est de souligner l’effet né- Choriorétinite séreuse centrale - complication faste des stéroïdes sur la choriorétinite séreuse cen- - corticoïdes trale (CRSC). Nous décrivons trois patients chez qui la CRSC est provoquée ou aggravée par les corticoï- des. Malgré les nombreuses publications, certains oph- talmologues ignorent les effets défavorables des cor- ticoïdes dans toutes ses formes sur la CRSC. Cer- tains les utilisent même dans le traitement de ces lésions. Les corticostéroïdes sont fréquemment pres- crits pour un vaste nombre d’affections. Les ophtal- mologues doivent être au courant de leurs compli- cations maculaires éventuelles. SAMENVATTING Dit artikel handelt over de schadelijke gevolgen van corticosteroïden op serosa centralis

zzzzzz * Department of , Ghent University Hospital, Belgium

received: 10.04.03 accepted: 18.06.03

Bull. Soc. belge Ophtalmol., 289, 35-41, 2003. 35 INTRODUCTION tamorphopsia and micropsia. This report des- cribes 3 patients: two patients suffering from Ocular side effects due to systemic or ocular ad- CSCR received steroids: under systemic form ministration of corticosteroids are well known in the first patient and by means of retrobulbar e.g. corticosteroid induced , poste- injections in the second patient. The third pa- rior subcapsular (6). This paper tient developed ocular problems during syste- highlights another -less known- complication of mic treatment with intravenous and peroral cor- corticosteroid treatment: central serous chorio- ticosteroids for bronchiolitis obliterans with or- . This retinal disorder can occur du- ganizing pneumonia (BOOP). ring treatment with corticosteroids administer- ed under various forms or may worsen in case it is treated with corticosteroids. CASE REPORTS

Central serous chorioretinopathy is characteri- Case 1 zed by the formation of a localized neurosen- sory caused by leakage of A 41-year-old male complained of blurred vi- fluid at the level of the retinal pigment epithe- sion in the right eye in December 2001. A dia- lium. It typically affects young and middle-aged gnosis of central serous chorioretinopathy was men, who present with symptoms of diminish- made. One week later, the left eye was affect- ed visual acuity, relative central , me- ed. A therapy with systemic corticosteroids (me-

ab

cd

Fig 1. Case 1: March 2002: − (a): FA of the right eye: pinpoint leakage point,cluster of focal lesions, PED − (b): FA of the left eye: smoke stack sign, PED − (c): OCT of the right eye: multiple PED and neurosensory detachments and diffuse − (d): OCT of the left eye: foveolar serous detachment

36 ab

Fig 2. Case 1: April 2002: − (a): OCT of the right eye: significant decrease of PED and neurosensory detachments after withdrawal of steroids − (b): OCT of the left eye: restored foveal depression, small PED

ab

Fig 3. Case 1: August 2002: − (a): OCT of the right eye: foveal depression with only a small amount of fluid beneath the sensory − (b): OCT of the left eye: normal aspect thylprednisolone 64 mg) was given. No im- the differential diagnosis, an infracyaninegreen provement of complaints or visual acuity oc- (ICG) angiography was performed. With this ex- curred. The patient was then referred to our de- amination no polypoidal vascular lesion was partment for second opinion in March 2002. seen. However transient choroidal hyperfluo- According to the patient, vision had further de- rescence with a washing out phenomenon was creased. He also complained of micropsia and noticed, highly suggestive for central serous disturbed colour perception. His best correct- choroidopathy. The corticosteroids were tapered. ed visual acuity was 7/10 in the right eye and Six weeks later, the patients symptoms worsen- 8/10 in the left eye. Fluorescein angiography ed. The best corrected visual acuity was now (FA) showed a pinpoint focus with late leak- 8/10 in both eyes. On OCT a significant de- age of dye, a cluster of focal lesions and pig- crease in size of the neurosensory detachments ment epithelial detachments (PED) in the right could be seen in the right eye (fig 2a) and the eye (fig 1a) and a serous detachment with typ- foveal depression was restored in the left eye ical smoke-stack sign and a small PED in the (fig 2b). Because FA showed a persistent leak- left eye (fig 1b). Optical coherence tomogra- age spot in the right eye, focal laser treatment phy (OCT) showed multiple PED’s, serous de- was applied. tachments and a diffuse macular oedema in the Another six weeks later, the patient reported im- right eye (fig 1c) and a serous detachment at provement of symptoms in both eyes. His best the fovea in the left eye (fig 1d). As on fluores- corrected visual acuity was 9/10 in the right eye cein angiography as well as OCT polypoidal and 10/10 in the left eye. On FA no dye leak- choroidal vasculopathy could be considered in age was seen in the right eye. In the left eye

37 ab

Fig 4. Case 1: September 2002: reactivation of the lesions due to steroids: − (a): FA of the left eye: leaking point with filling of a large bulla − (b): OCT of the same eye: large serous detachment with small PED there was still a small PED, but no further le- marked scotoma in the left eye on Amsler test- sions were seen. No treatment was given. ing. On FA of the right eye no leaking points Three months later (7 months after the initial could be seen, but in the left eye a leaking point symptoms) the patient mentioned improved vi- with subsequent filling of a large bulla was no- sual acuity but still some and ticed (fig 4a). OCT of the right eye showed no difficulties in colour perception. His best cor- changes, whereas a large serous detachment rected visual acuity was 10/10 in the right eye was seen in the left eye (fig 4b). As the sys- and 12/10 in the left eye. He read Parinaud 1 temic treatment had already been stopped, we with both eyes. The Amsler test showed dis- asked the patient to withdraw his nasal spray crete metamorphopsia and two small scoto- as soon as possible. Six weeks later he had less mas in the right eye, and was nomal in the left visual problems and on OCT the serous detach- eye. On colour vision testing, he had an ac- ment was no longer visible. quired blue-yellow defect, more pronounced in the right than in the left eye. Automated pe- Case 2 rimetry showed some relative defects, possi- bly related to poor concentration. OCT of the In March 1997, a 58-year-old male was re- right eye showed now a foveal depression with ferred to our department. Since more than 10 only residual fluid beneath the sensory retina years he had recurrent episodes of blurred vi- (fig 3a). OCT of the left eye was normal (fig 3b). sion in both eyes due to chronic central serous FA showed a hyperfluorescent area with sur- chorioretinopathy. He had received multiple re- rounding lipoid exudates in the right eye and a trobulbar injections with corticosteroids in both small PED in the left eye. As there were no ac- eyes and laser photocoagulation in the left eye. tive lesions any more, the patient was asked to He noticed a recent decrease in visual acuity return for follow up after six months. in the left eye. His best corrected visual acuity Unfortunately, the patient came back four weeks in the right eye was 10/10 and 2/10 in the left later with new complaints. Because of chronic eye. FA of the right eye showed an important sinusitis, the oto-rhino-laryngologist started me- diffuse retinal pigment epithelial atrophy with- thylprednisolone 64 mg orally as well as a na- out obvious leaking points. In the left eye ex- sal corticosteroidspray. Four days later our pa- tensive retinal pigment epithelial atrophy was tient noticed a decrease in visual acuity and a associated with an area of diffusion surround- scotoma in the left eye. The best corrected vi- ed by hemorrhages and lipid exudates, strong- sual acuity was 10/10 in both eyes with a ly suggestive for a subretinal neovascular mem-

38 brane. Direct photocoagulation of this lesion logical medication or treatment with corticos- was subsequently performed. Two weeks later teroids (1,3,4,7-16,18,19,21,22,25). his visual acuity remained unchanged in the Previous reports describe the onset of CSCR or right eye and improved to 4/10 in the left eye. aggravation of pre-existing lesions by cortico- FA of the left eye showed less exudates and steroids regardless of their route of administra- hemorrhages. A control one month later showed tion: not only systemic administration (intrave- no changes in visual acuity or FA. The patient nously, intramuscular, peroral) but also intra- did not come back until five years later in Feb- joint and epidural injection, intranasal spray, in- ruary 2002 for a routine examination. His best haled corticosteroids, topical skin application corrected visual acuity was 8/10 in the right eye and retrobulbar injections (1,3,4,8,10,13- and counting fingers in the left eye. On FA large 15,21,22). areas of pigment epithelial atrophy without dif- The daily dose is of greater influence in the on- fusion were seen in both eyes and a fibrotic scar set than the total dosage and frequently symp- without leakage in the left eye. OCT of the right toms can arise by increasing the daily dose eye showed an irregular RPE with slight ede- (1,18,24). The latency time is shorter with high- ma and a fibrotic scar in the left eye. This re- er doses and recurrences occur earlier when the mained unchanged 6 months later. dosage of corticosteroids is higher (3,5,24). Re- currences can also occur in patients who had Case 3 previous episodes of CSCR independent of cor- ticosteroid use (3,10). A 56-year-old female had an episode of bron- The patients are often older than the patients chiolitis obliterans with organizing pneumonia with the idiopathic type of CSCR (19,24). (BOOP) in June 2002. A treatment with sys- The lesions in corticosteroid-related CSCR are temic corticosteroids was started, intravenous- frequently bilateral (3,19). ly at first, followed by oral methylprednisolo- The lesions are typically localized serous de- ne. Four weeks later the patient complained of tachments of neuroretina and/or the RPE. How- blurred vision and metamorphopsia in the right ever, atypical forms such as chronic CSCR are eye. Her best corrected visual acuity was 5/10 more likely associated with the use of steroids in her right eye and 10/10 in the left eye. FA (3,12,18,22). showed a perifoveolar leakage point in the right Subretinal neovascularization is also here a pos- eye and some hyperfluorescent spots due to sible complication (20), as seen in our second pigment epithelial alterations in the left eye. patient. In this patient, the choroidal neovas- ICG angiography confirmed the diagnosis of cularization can be a complication of CSCR, the central serous chorioretinopathy. On OCT a se- previously performed laser treatment or both. rous retinal detachment was seen in the right A decrease or discontinuation of the steroids eye, the macular profile in the left eye was nor- may improve visual symptoms (1,4,5,13,18, mal. As the steroids were already tapered, no 21,23). Laser photocoagulation can be per- local treatment was advised. Six weeks later, formed either for a persistent leakage spot or the visual acuity in the right eye improved to for subretinal neovascularization (3,8,13,20,21). 9/10. On FA the neurosensory detachment was Acetazolamide treatment for CSCR shortens the less extensive. time for subjective and objective improvement, but has no effect on visual outcome or recur- rence rate (17). In vitro studies with bovine DISCUSSION RPE cells showed a beneficial effect of brimoni- dine at the level of the rupture in the RPE: an The physiopathogenesis of CSCR remains un- alpha-1-receptor on the apical side of RPE cells clear. is stimulated by the aspecific alpha-agonist ef- A number of predisposing factors have been re- fect with subsequent resorption of subretinal ported: type A personality, emotional strain, hy- fluid (2). This has not been confirmed clinical- pertension, pregnancy, organ transplantation, ly yet. systemic lupus erythematosus, increased lev- Physicians should be prudent in using steroids els of endogenous cortisol, psychopharmaco- and a periodic ophthalmologic examination is

39 recommended (21). CSCR patients should avoid during systemic corticosteroid therapy, the use of corticosteroids in any form, unless Ophthalmology 1995; 102: 737-747 they cannot be treated with alternative medi- (9) GASS J.D.M. − Central serous chorioretinopa- cations (1,3,4,8,10,15,22,23). thy and white subretinal exudation during preg- nancy, Arch Ophthalmol 1991; 109: 677-681 (10) HAIMOVICI R., GRAGOUDAS E.S., DUKER J.S., CONCLUSION SJAARDA R.N., ELIOTT D. − Central serous chorioretinopathy associated with inhaled or Despite several reports indicating the adverse intranasal corticosteroids, Ophthalmology 1997; effects of corticosteroids on the severity and 104: 1653-1660 (11) HARADA T., HARADA K. − Six cases of cent- course of CSCR, corticosteroids are still used ral serous choriodopathy induced by systemic as a treatment for CSCR. corticosteroid therapy, Doc Ophthalmol 1985; With these case reports we want to demon- 37-44 strate the causal relationship between steroids (12) IIDA T., SPAIDE R.F., NEGRAO S.G., CARVAL- and CSCR. HO C.A., YANNUZZI LA. − Central serous cho- rioretinopathy after epidural corticosteroid in- REFERENCES jection, Am J Ophthalmol 2001; 132: 423- 425 (13) JAMPOL L.M., WEINREB R., YANNUZZI L. − (1) ABU EL-ASRAR A.M. − Central serous chorio- Involvement of corticosteroids and catechola- retinopathy complicating systemic corticoste- mines in the pathogenesis of central serous roid therapy, Eur J Ophthalmol 1997; 7: 297- chorioretinopathy: a rationale for new treat- 300 − ment strategies, Ophthalmology 2002; 109: (2) ARNDT CF. Rôle des récepteurs aux corti- 1765-1766 coïdes et gabaergiques dans le transport des (14) KAO L.Y. − Bilateral serous retinal detachment molécules organiques à travers l’épithélium resembling central serous chorioretinopathy pigmentaire de la rétine, Doctoral thesis, July following epidural steroid injection, Retina 1998; 2, 2001 18: 479-481 (3) BOUZAS E.A., KARADIMAS P., POURNARAS (15) LIN J.M., TSAI Y.Y. − Retinal pigment epithe- − C.J. Central serous chorioretinopathy and lial detachment in the fellow eye of a patient glucocorticoids, Surv Ophthalmol 2002; 47: with unilateral central serous chorioretinopa- 431-448 thy treated with steroid, Retina 2001; 21: 377- (4) CARVALHO-RECCHIA C.A., YANNUZZI L.A., 379 NEGRAO S., SPAIDE R.F., FREUND K.B., RO- (16) MARMOR M.F. − On the cause of serous de- DRIGUEZ-COLEMAN H., LENHARO M., IIDA tachments and acute central serous choriore- T. − Corticosteroids and central serous chorio- tinopathy, Br J Ophthalmol 1997; 81: 812- retinopathy, Ophthalmology 2002; 109: 1834- 813 1837 (17) PIKKEL J., BEIRAN I., OPHIR A., MILLER B. (5) CHAINE G., HAOUAT M., MENARD-MOL- − Acetazolamide for central serous retinopa- CARD C., FAVARD C., VIGNAL-CLERMONT C., thy, Ophthalmology 2002; 109: 1723-1725 CAMPINCHI-TARDY F., MASSIN P., GAUDRIC (18) POLAK B.C., BAARSMA G.S., SNYERS B. − A., BADELON I., NICOLON L., SABATIER P., Diffuse retinal pigment epitheliopathy compli- GUILLEVIN L. − Choriorétinite séreuse centra- cating systemic corticosteroid treatment, Br J le et corticothérapie systémique, J Fr Ophtal- Ophthalmol 1995; 79: 922-925 mol 2001;24:139-146 (19) QUILLEN D.A., GASS D.M., BROD R.D., GARD- (6) FRANCOIS J. − Effets secondaires et compli- NER T.W., BLANKENSHIP G.W., GOTTLIEB cations ophtalmologiques de la cortisonothéra- J.L. − Central serous chorioretinopathy in wo- pie, Bull. Soc. belge Ophtalmol. 1979; 186: men, Ophthalmology 1996; 103: 72-79 47-55 (20) SPAIDE R.F., CAMPEAS L., HAAS A., YAN- (7) GARG S.P., DADA T., TALWAR D., BISWAS NUZZI L.A., FISHER Y.L.,GUYER D.R., SLAK- N.R. − Endogenous cortisol profile in patients TER J.S., SORENSON J.A., ORLOCK D.A. − withcentralserouschorioretinopathy,BrJOph- Central serous chorioretinopathy in younger thalmol 1997; 81: 962-964 and older adults, Ophthalmology 1996; 103: (8) GASS J.D.M., LITTLE H. − Bilateral bullous 2070-2080 exudative retinal detachment complicating (21) SPRAUL C.W., LANG G.E., LANG G.K. − Reti- idiopathic central serous chorioretinopathy nal pigment epithelial changes associated with

40 systemic corticosteroid treatment: report of ca- (25) YANNUZZI L.A. − Type-A behavior and central ses and review of the literature, Ophthalmo- serous chorioretinopathy, Retina 1987; 7: 111- logica 1998; 212: 142-148 130. (22) TITTL M.K., SPAIDE R.F., WONG D., PILOT- TO E., YANNUZZI L.A., FISHER Y.L.,FREUND B., GUYER D.R., SLAKTER J.S., SORENSON zzzzzz J.A. − Systemic findings associated with cen- tral serous chorioretinopathy, Am J Ophthal- This study was supported by a grant of: Les Amis des mol 1999; 128: 63-68 Aveugles, Ghlin (23) WAKAKURA M., ISHIKAWA S. − Central serous chorioretinopathy complicating systemic cor- Request for reprints to: Prof. J.J. De Laey, ticosteroid treatment, Br J Ophthalmol 1984; Department of Ophthalmology, 68: 329-331 Ghent University Hospital, (24) WAKAKURA M., SONG E., ISHIKAWA S. − Cor- De Pintelaan 185, ticosteroid-induced central serous chorioreti- B- 9000 Ghent, nopathy, Jpn J Opthalmol 1997; 41:180-185 Belgium

41